REFERENCES
1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-49.
2. Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000;406:747-52.
3. Ensenyat-mendez M, Llinàs-arias P, Orozco JIJ, et al. Current triple-negative breast cancer subtypes: dissecting the most aggressive form of breast cancer. Front Oncol 2021;11:681476.
4. Yin L, Duan J, Bian X, Yu S. Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res 2020;22:61.
5. Asleh K, Riaz N, Nielsen TO. Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications. J Exp Clin Cancer Res 2022;41:265.
6. Xie J, Ye F, Deng X, et al. Circular RNA: a promising new star of vaccine. J Transl Int Med 2023;11:372-81.
7. Vo JN, Cieslik M, Zhang Y, et al. The landscape of circular RNA in cancer. Cell 2019;176:869-81.e13.
8. Zeng Y, Zou Y, Gao G, et al. The biogenesis, function and clinical significance of circular RNAs in breast cancer. Cancer Bio Med 2021;19:14-29.
9. Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature 2013;495:384-8.
10. Zeng Y, Du W, Huang Z, et al. Hsa_circ_0060467 promotes breast cancer liver metastasis by complexing with eIF4A3 and sponging miR-1205. Cell Death Discov 2023;9:153.
11. Ye F, Gao G, Zou Y, et al. circFBXW7 inhibits malignant progression by sponging miR-197-3p and encoding a 185-aa protein in triple-negative breast cancer. Mol Ther Nucleic Acids 2019;18:88-98.
12. Hsu MT, Coca-Prados M. Electron microscopic evidence for the circular form of RNA in the cytoplasm of eukaryotic cells. Nature 1979;280:339-40.
13. Cocquerelle C, Mascrez B, Hétuin D, Bailleul B. Mis-splicing yields circular RNA molecules. FASEB J 1993;7:155-60.
14. Chen L, Wang C, Sun H, et al. The bioinformatics toolbox for circRNA discovery and analysis. Brief Bioinform 2021;22:1706-28.
15. Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 2013;495:333-8.
16. Haynes B, Sarma A, Nangia-makker P, Shekhar MP. Breast cancer complexity: implications of intratumoral heterogeneity in clinical management. Cancer Metastasis Rev 2017;36:547-55.
17. Zhang C, Zhang B. RNA therapeutics: updates and future potential. Sci China Life Sci 2023;66:12-30.
18. Rong Z, Xu J, Shi S, et al. Circular RNA in pancreatic cancer: a novel avenue for the roles of diagnosis and treatment. Theranostics 2021;11:2755-69.
19. Liu CX, Chen LL. Circular RNAs: characterization, cellular roles, and applications. Cell 2022;185:2016-34.
20. Li X, Zhang JL, Lei YN, et al. Linking circular intronic RNA degradation and function in transcription by RNase H1. Sci China Life Sci 2021;64:1795-809.
21. Conn VM, Hugouvieux V, Nayak A, et al. A circRNA from SEPALLATA3 regulates splicing of its cognate mRNA through R-loop formation. Nature Plants 2017;3:17053.
22. Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 2013;19:141-57.
23. Zhang X, Wang H, Zhang Y, Lu X, Chen L, Yang L. Complementary sequence-mediated exon circularization. Cell 2014;159:134-47.
24. Conn S, Pillman K, Toubia J, et al. The RNA binding protein quaking regulates formation of circRNAs. Cell 2015;160:1125-34.
25. Errichelli L, Dini Modigliani S, Laneve P, et al. FUS affects circular RNA expression in murine embryonic stem cell-derived motor neurons. Nat Commun 2017;8:14741.
26. Ashwal-fluss R, Meyer M, Pamudurti N, et al. circRNA biogenesis competes with pre-mRNA splicing. Molecular Cell 2014;56:55-66.
27. Guo Y, Yang J, Huang Q, et al. Circular RNAs and their roles in head and neck cancers. Mol Cancer 2019;18:44.
28. Zhang Y, Zhang X, Chen T, et al. Circular intronic long noncoding RNAs. Mol Cell 2013;51:792-806.
29. Hoque P, Romero B, Akins RE, Batish M. Exploring the multifaceted biologically relevant roles of circRNAs: from regulation, translation to biomarkers. Cells 2023;12:2813.
30. Xin R, Gao Y, Gao Y, et al. isoCirc catalogs full-length circular RNA isoforms in human transcriptomes. Nat Commun 2021;12:266.
31. Chiang TW, Jhong SE, Chen YC, Chen CY, Wu WS, Chuang TJ. FL-circAS: an integrative resource and analysis for full-length sequences and alternative splicing of circular RNAs with nanopore sequencing. Nucleic Acids Res 2024;52:D115-23.
33. Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature 2014;505:344-52.
34. Verduci L, Strano S, Yarden Y, Blandino G. The circ RNA-micro RNA code: emerging implications for cancer diagnosis and treatment. Mol Oncol 2019;13:669-80.
35. Zou Y, Zheng S, Deng X, et al. The role of circular RNA CDR1as/ciRS-7 in regulating tumor microenvironment: a pan-cancer analysis. Biomolecules 2019;9:429.
36. Sang M, Meng L, Liu S, et al. Circular RNA ciRS-7 maintains metastatic phenotypes as a ceRNA of miR-1299 to target MMPs. Mol Cancer Res 2018;16:1665-75.
37. Li Y, Jiang B, Zeng L, et al. Adipocyte-derived exosomes promote the progression of triple-negative breast cancer through circCRIM1-dependent OGA activation. Environ Res 2023;239:117266.
38. Ding L, Xie Z. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer. Exp Mol Pathol 2021;123:104704.
39. Ma J, Chen C, Fan Z, et al. CircEGFR reduces the sensitivity of pirarubicin and regulates the malignant progression of triple-negative breast cancer via the miR-1299/EGFR axis. Int J Biol Macromol 2023;244:125295.
40. Huang S, Xie J, Lei S, Fan P, Zhang C, Huang Z. CircDUSP1 regulates tumor growth, metastasis, and paclitaxel sensitivity in triple-negative breast cancer by targeting miR-761/DACT2 signaling axis. Mol Carcinog 2023;62:450-63.
41. Dou D, Ren X, Han M, et al. CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis. Cancer Cell Int 2020;20:454.
42. He ZY, Zhuo RG, Yang SP, et al. CircNCOR1 regulates breast cancer radiotherapy efficacy by regulating CDK2 via hsa-miR-638 binding. Cell Signal 2023;109:110787.
43. Wang F, Lu Q, Yu H, Zhang XM. The circular RNA circFGFR4 facilitates resistance to anti-PD-1 of triple-negative breast cancer by targeting the miR-185-5p/CXCR4 axis. Cancer Manag Res 2023;15:825-35.
44. Wang Z, Li Y, Yang J, et al. Circ-TRIO promotes TNBC progression by regulating the miR-432-5p/CCDC58 axis. Cell Death Dis 2022;13:776.
45. He Q, Hao Q, Wu Y, Vadgama JV, Jiang Y. CircRAD54L2 promotes triple-negative breast cancer progression by regulating the miR-888 family/PDK1 axis. Life Sci 2023;312:121128.
46. Shao G, Fan X, Zhang P, Liu X, Huang L, Ji S. Circ_0004676 exacerbates triple-negative breast cancer progression through regulation of the miR-377-3p/E2F6/PNO1 axis. Cell Biol Toxicol 2023;39:2183-205.
47. Zan X, Li W, Wang G, et al. Circ-CSNK1G1 promotes cell proliferation, migration, invasion and glycolysis metabolism during triple-negative breast cancer progression by modulating the miR-28-5p/LDHA pathway. Reprod Biol Endocrinol 2022;20:138.
48. Gong G, She J, Fu D, Zhen D, Zhang B. CircUBR5 acts as a ceRNA for miR-1179 to up-regulate UBR5 and to promote malignancy of triple-negative breast cancer. Am J Cancer Res 2022;12:2539-57.
49. Cui S, Zhang Y, Xing L, Li R, Piao Y, Liu H. Circular RNA dehydrodolichyl diphosphate synthase facilitated triple-negative breast cancer progression via miR-362-3p/DDX5 axis. Environ Toxicol 2022;37:1483-94.
50. Wang X, Song H, Fang L, Wu T. EIF4A3-mediated circPRKCI expression promotes triple-negative breast cancer progression by regulating WBP2 and PI3K/AKT signaling pathway. Cell Death Discov 2022;8:92.
51. Wang M, Chen D, Zhang H, Luo C. Circular RNA circPTK2 modulates migration and invasion via miR-136/NFIB signaling on triple-negative breast cancer cells in vitro. Inflamm Res 2022;71:409-21.
52. Wang L, Yang X, Zhou F, Sun X, Li S. Circular RNA UBAP2 facilitates the cisplatin resistance of triple-negative breast cancer via microRNA-300/anti-silencing function 1B histone chaperone/PI3K/AKT/mTOR axis. Bioengineered 2022;13:7197-208.
53. Maimaiti Y, Zhang N, Zhang Y, Zhou J, Song H, Wang S. CircFAM64A enhances cellular processes in triple-negative breast cancer by targeting the miR-149-5p/CDT1 axis. Environ Toxicol 2022;37:1081-92.
54. Li J, Gao X, Zhang Z, et al. CircCD44 plays oncogenic roles in triple-negative breast cancer by modulating the miR-502-5p/KRAS and IGF2BP2/Myc axes. Mol Cancer 2021;20:138.
55. Xing Z, Wang R, Wang X, et al. CircRNA circ-PDCD11 promotes triple-negative breast cancer progression via enhancing aerobic glycolysis. Cell Death Discov 2021;7:218.
56. Huang Y, Zheng S, Lin Y, Ke L. Circular RNA circ-ERBB2 elevates the warburg effect and facilitates triple-negative breast cancer growth by the microRNA 136-5p/pyruvate dehydrogenase kinase 4 axis. Mol Cell Biol 2021;41:e00609-20.
57. Wang L, Zhou Y, Jiang L, et al. CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K/AKT pathway. Mol Cancer 2021;20:43.
58. Fan Y, Wang J, Jin W, et al. CircNR3C2 promotes HRD1-mediated tumor-suppressive effect via sponging miR-513a-3p in triple-negative breast cancer. Mol Cancer 2021;20:25.
59. Yang SJ, Wang DD, Zhong SL, et al. Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in triple-negative breast cancer (TNBC) through miR-637/Akt1/β-catenin (cyclin D1) axis. Cell Death Dis 2021;12:420.
60. Wang X, Xue B, Zhang Y, Guo G, Duan X, Dou D. Up-regulated circBACH2 contributes to cell proliferation, invasion, and migration of triple-negative breast cancer. Cell Death Dis 2021;12:412.
61. Du C, Zhang J, Zhang L, Zhang Y, Wang Y, Li J. Hsa_circRNA_102229 facilitates the progression of triple-negative breast cancer via regulating the miR-152-3p/PFTK1 pathway. J Gene Med 2021;23:e3365.
62. Li H, Xu W, Xia Z, et al. Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling. Aging 2021;13:4522-51.
63. Xing L, Yang R, Wang X, et al. The circRNA circIFI30 promotes progression of triple-negative breast cancer and correlates with prognosis. Aging 2020;12:10983-1003.
64. He D, Yang X, Kuang W, Huang G, Liu X, Zhang Y. The novel circular RNA circ-PGAP3 promotes the proliferation and invasion of triple negative breast cancer by regulating the miR-330-3p/Myc axis. Onco Targets Ther 2020;13:10149-59.
65. Kong Y, Yang L, Wei W, et al. CircPLK1 sponges miR-296-5p to facilitate triple-negative breast cancer progression. Epigenomics 2019;11:1163-76.
66. Wu S, Lu J, Zhu H, et al. A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer. Cancer Lett 2024;581:216508.
67. Chen B, Wei W, Huang X, et al. circEPSTI1 as a prognostic marker and mediator of triple-negative breast cancer progression. Theranostics 2018;8:4003-15.
68. Dudekula DB, Panda AC, Grammatikakis I, De S, Abdelmohsen K, Gorospe M. CircInteractome: a web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biology 2016;13:34-42.
69. Pamudurti NR, Patop IL, Krishnamoorthy A, et al. circMbl functions in cis and in trans to regulate gene expression and physiology in a tissue-specific fashion. Cell Rep 2022;39:110740.
70. Luo P, Gong Y, Weng J, et al. CircKIF4A combines EIF4A3 to stabilize SDC1 expression to activate c-src/FAK and promotes TNBC progression. Cell Signal 2023;108:110690.
71. Gao H, Tuluhong D, Li X, et al. CircSNX25 mediated by SP1 promotes the carcinogenesis and development of triple-negative breast cancer. Cell Signal 2023;109:110776.
72. Turco C, Esposito G, Iaiza A, et al. MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer. Commun Biol 2022;5:598.
73. Song X, Chen B, Liang Y, et al. CircEIF3H-IGF2BP2-HuR scaffold complex promotes TNBC progression via stabilizing HSPD1/RBM8A/G3BP1 mRNA. Cell Death Discov 2022;8:261.
74. Abe N, Matsumoto K, Nishihara M, et al. Rolling circle translation of circular RNA in living human cells. Sci Rep 2015;5:16435.
75. Meyer K, Patil D, Zhou J, et al. 5′ UTR m6A Promotes cap-independent translation. Cell 2015;163:999-1010.
76. Song R, Guo P, Ren X, et al. A novel polypeptide CAPG-171aa encoded by circCAPG plays a critical role in triple-negative breast cancer. Mol Cancer 2023;22:104.
77. Li Y, Wang Z, Su P, et al. circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing MYH9 and activating the Wnt/beta-catenin pathway. Mol Ther 2022;30:415-30.
78. Wang X, Jian W, Luo Q, Fang L. CircSEMA4B inhibits the progression of breast cancer by encoding a novel protein SEMA4B-211aa and regulating AKT phosphorylation. Cell Death Dis 2022;13:794.
79. Li J, Ma M, Yang X, et al. Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab. Mol Cancer 2020;19:142.
80. Hao R, Zhang L, Si Y, et al. A novel feedback regulated loop of circRRM2-IGF2BP1-MYC promotes breast cancer metastasis. Cancer Cell Int 2023;23:54.
81. Ji C, Zhu L, Fang L. Hsa_circ_0000851 promotes PDK1/p-AKT-mediated cell proliferation and migration by regulating miR-1183 in triple-negative breast cancer. Cell Signal 2023;101:110494.
82. Liu P, Wang Z, Ou X, et al. The FUS/circEZH2/KLF5/ feedback loop contributes to CXCR4-induced liver metastasis of breast cancer by enhancing epithelial-mesenchymal transition. Mol Cancer 2022;21:198.
83. Ju C, Zhou M, Du D, et al. EIF4A3-mediated circ_0042881 activates the RAS pathway via miR-217/SOS1 axis to facilitate breast cancer progression. Cell Death Dis 2023;14:559.
84. Huang X, Tan W, Liu Z, et al. EIF4A3-induced circZFAND6 promotes breast cancer proliferation and metastasis through the miR-647/FASN axis. Life Sci 2023;324:121745.
85. Zheng W, Wang X, Yu Y, Ji C, Fang L. CircRNF10-DHX15 interaction suppressed breast cancer progression by antagonizing DHX15-NF-κB p65 positive feedback loop. Cell Mol Biol Lett 2023;28:34.
86. Meng L, Chang S, Sang Y, et al. Circular RNA circCCDC85A inhibits breast cancer progression via acting as a miR-550a-5p sponge to enhance MOB1A expression. Breast Cancer Res 2022;24:1.
88. Safi A, Saberiyan M, Sanaei M, et al. The role of noncoding RNAs in metabolic reprogramming of cancer cells. Cell Mol Biol Lett 2023;28:37.
89. Cai Z, Hu Y, Liao K, Li H, Chen D, Ju H. Circular RNAs: emerging regulators of glucose metabolism in cancer. Cancer Lett 2023;552:215978.
90. Ma W, Sun X, Zhang S, Chen Z, Yu J. Circ_0039960 regulates growth and Warburg effect of breast cancer cells via modulating miR-1178/PRMT7 axis. Mol Cell Probes 2022;64:101829.
91. Dou D, Ren X, Han M, et al. Circ_0008039 supports breast cancer cell proliferation, migration, invasion, and glycolysis by regulating the miR-140-3p/SKA2 axis. Mol Oncol 2021;15:697-709.
92. Cao L, Wang M, Dong Y, et al. Circular RNA circRNF20 promotes breast cancer tumorigenesis and Warburg effect through miR-487a/HIF-1α/HK2. Cell Death Dis 2020;11:145.
93. Tian J, Liu S, Yu C, Wu L, Wang L. The role of non-coding RNAs in breast cancer drug resistance. Front Oncol 2021;11:702082.
94. Tang AH, Hoefer RA, Guye ML, Bear HD. Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancer. Cancer Drug Resist 2022;5:691-702.
95. Xia M, Zu X, Chen Z, Wen G, Zhong J. Noncoding RNAs in triple negative breast cancer: mechanisms for chemoresistance. Cancer Lett 2021;523:100-10.
96. Misir S, Ozer Yaman S, Petrović N, Sumer C, Hepokur C, Aliyazicioglu Y. circRNAs in drug resistance of breast cancer. Oncol Res 2022;30:157-72.
97. Wang X, Chen T, Li C, et al. CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR. J Hematol Oncol 2022;15:122.
98. Wang X, Yao Y, Jin M. Circ-0001068 is a novel biomarker for ovarian cancer and inducer of PD1 expression in T cells. Aging 2020;12:19095-106.
99. Wang J, Zhao X, Wang Y, et al. circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma. Cell Death Dis 2020;11:32.
100. Xu Y, Zhao J, Gao C, et al. Hsa_circ_0136666 activates Treg-mediated immune escape of colorectal cancer via miR-497/PD-L1 pathway. Cell Signal 2021;86:110095.
101. Gao C, Xu Y, J Qi L, Bao YF, Zhang L, Zheng L. CircRNA VIM silence synergizes with sevoflurane to inhibit immune escape and multiple oncogenic activities of esophageal cancer by simultaneously regulating miR-124/PD-L1 axis. Cell Biol Toxicol 2022;38:825-45.
102. Fu X, Sun G, Tu S, et al. Hsa_circ_0046523 mediates an immunosuppressive tumor microenvironment by regulating MiR-148a-3p/PD-L1 axis in pancreatic cancer. Front Oncol 2022;12:877376.
103. Yang Z, Chen W, Wang Y, Qin M, Ji Y. CircKRT1 drives tumor progression and immune evasion in oral squamous cell carcinoma by sponging miR-495-3p to regulate PDL1 expression. Cell Biol Int 2021;45:1423-35.
104. Luo Y, Tang W, Xiang S, Feng J, Zu X. Non-coding RNAs in breast cancer: implications for programmed cell death. Cancer Lett 2022;550:215929.
105. Zheng Y, Ren S, Zhang Y, et al. Circular RNA circWWC3 augments breast cancer progression through promoting M2 macrophage polarization and tumor immune escape via regulating the expression and secretion of IL-4. Cancer Cell Int 2022;22:264.
106. Lu C, Shi W, Hu W, et al. Endoplasmic reticulum stress promotes breast cancer cells to release exosomes circ_0001142 and induces M2 polarization of macrophages to regulate tumor progression. Pharmacol Res 2022;177:106098.
107. Huang X, Song C, Zhang J, Zhu L, Tang H. Circular RNAs in breast cancer diagnosis, treatment and prognosis. Oncol Res 2024;32:241-9.
108. Wang B, Chen H, Deng Y, et al. CircDNAJC11 interacts with TAF15 to promote breast cancer progression via enhancing MAPK6 expression and activating the MAPK signaling pathway. J Transl Med 2023;21:186.
109. Liu Y, Liu Y, He Y, et al. Hypoxia-induced FUS-circTBC1D14 stress granules promote autophagy in TNBC. Adv Sci 2023;10:2204988.
110. Darbeheshti F, Mansoori Y, Azizi-tabesh G, et al. Evaluation of circ_0000977-mediated regulatory network in breast cancer: a potential discriminative biomarker for triple-negative tumors. Biochem Genet 2023;61:1487-508.
111. Darbeheshti F, Zokaei E, Mansoori Y, et al. Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3. Cancer Cell Int 2021;21:312.
112. Zheng X, Huang M, Xing L, et al. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer. Mol Cancer 2020;19:73.
113. Yu J, Shen W, Xu J, Gong B, Gao B, Zhu J. circUSP42 is downregulated in triple-negative breast cancer and associated with poor prognosis. Technol Cancer Res Treat 2020;19:153303382095082.
114. Liu P, Zou Y, Li X, et al. circGNB1 facilitates triple-negative breast cancer progression by regulating miR-141-5p-IGF1R axis. Front Genet 2020;11:193.
115. Li Y, Shi P, Zheng T, Ying Z, Jiang D. Circular RNA hsa_circ_0131242 promotes triple-negative breast cancer progression by sponging hsa-miR-2682. Onco Targets Ther 2020;13:4791-8.
116. Zou Y, Zheng S, Xiao W, et al. circRAD18 sponges miR-208a/3164 to promote triple-negative breast cancer progression through regulating IGF1 and FGF2 expression. Carcinogenesis 2019;40:1469-79.
117. Xu J, Shao C, Wang X, et al. circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis. Cell Death Dis 2019;10:175.
118. Zhang J, Xu HD, Xing XJ, Liang ZT, Xia ZH, Zhao Y. CircRNA_069718 promotes cell proliferation and invasion in triple-negative breast cancer by activating Wnt/β-catenin pathway. Eur Rev Med Pharmacol Sci 2019;23:5315-22.
119. Xiao W, Zheng S, Zou Y, et al. CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1. Aging 2019;11:12043-56.
120. Wang ST, Liu LB, Li XM, et al. Circ-ITCH regulates triple-negative breast cancer progression through the Wnt/β-catenin pathway. Neoplasma 2019;66:232-9.
121. Tang H, Huang X, Wang J, et al. circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer. Mol Cancer 2019;18:23.
122. Zeng K, He B, Yang BB, et al. The pro-metastasis effect of circANKS1B in breast cancer. Mol Cancer 2018;17:160.
123. He R, Liu P, Xie X, et al. circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a. J Exp Clin Cancer Res 2017;36:145.
